@sofiahairhealth's DHT blocking claims, fact-checked
Quick answer
Androgenetic alopecia involves androgen-mediated miniaturization of hair follicles, with DHT playing a significant role in genetically predisposed individuals, though the picture in women is more complex and often involves multiple hormonal factors beyond DHT alone. Sofia's video presents a supplement and topical stack as a primary intervention, but the clinical standard of care for androgenetic alopecia remains FDA-approved minoxidil and, where appropriate, prescription 5-alpha reductase inhibitors like finasteride. For patients on TRT or other hormonal therapies, hair loss management should be coordinated with the prescribing clinician, as exogenous testosterone converts to DHT and can accelerate follicle miniaturization.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @sofiahairhealth actually say?
Sofia listed five daily habits she claims will "block DHT, the hair loss hormone": topical melatonin, topical caffeine, saw palmetto, ketoconazole shampoo, and pumpkin seed oil. She ranked them by effectiveness and cited specific numbers, including a 27% hair growth increase from saw palmetto and a 40% increase from pumpkin seed oil "proven in a study in 2014." She also briefly flagged prescription DHT blockers as a fallback.
The video is framed as a complete daily protocol, which is where some of the trouble starts. Saying you should be "doing all of these things every single day" implies these are low-risk, interchangeable interventions with solid evidentiary backing. Some are. Some are not. And a few of the statistics she cites deserve a closer look before you go stacking supplements.
Does the science back this up?
Partially, and unevenly. The strongest evidence here belongs to ketoconazole, and Sofia undersells it by burying it at number two. Pumpkin seed oil gets the top slot based largely on a single small study. That ordering reflects a common TikTok problem: mixing reasonably good evidence with cherry-picked trial data and presenting it all with equal confidence.
Ketoconazole 2% shampoo has multiple randomized controlled trials behind it, including Piérard-Franchimont et al. (1998, Dermatology) showing it comparable to 2% minoxidil for hair density in androgenetic alopecia. Saw palmetto has modest but real support. Dhurat et al. (2023, JEADV) found a 27% increase in hair count over 24 weeks compared to placebo, which tracks with Sofia's figure. Pumpkin seed oil comes from one 2014 RCT by Cho et al. (Journal of Evidence-Based Complementary and Alternative Medicine) involving 76 men, showing a 40% increase in hair count. That's real, but 76 men, one trial, male-only population. Topical melatonin has preliminary data from Fischer et al. (2004, British Journal of Dermatology), but it's far from settled. Topical caffeine has in vitro and some clinical data, but "blocking DHT" is an oversimplification of its likely mechanism.
What did they get wrong (or right)?
Let's start with what she got right: ketoconazole shampoo is genuinely one of the better-supported topical options for androgenetic alopecia, and recommending 2% concentration twice weekly is consistent with dermatology guidance. The saw palmetto figure she cites is traceable to a real trial. She also correctly says these aren't replacements for prescription treatments.
Where she goes wrong is in the mechanism claims. Calling DHT "the hair loss hormone" flattens a complicated picture, especially for women, where androgenetic alopecia involves multiple androgens and androgen receptor sensitivity, not just circulating DHT. Saying topical caffeine "blocks DHT" is inaccurate. The leading hypothesis is that caffeine inhibits phosphodiesterase, which prolongs the anagen (growth) phase. That's not DHT blockade. For melatonin, she says it "blocks DHT if you apply it to your scalp," but the mechanism is still under investigation and describing it flatly as a DHT blocker overstates what the evidence shows. Ranking pumpkin seed oil as number one over ketoconazole, which has far more clinical support, is the most misleading editorial choice in the video.
What should you actually know?
If you have androgenetic alopecia, the two interventions with the strongest evidence base are still FDA-approved minoxidil and prescription finasteride or dutasteride, neither of which Sofia mentions except as a vague afterthought. That omission matters because a video reaching nearly 500,000 people could reasonably lead someone to spend months cycling through supplements before getting actual treatment.
The interventions she mentions are not harmful in isolation, but "doing all of these things every single day" is not a clinical protocol. Ketoconazole twice weekly is reasonable. Daily pumpkin seed oil supplements are fine but based on thin evidence. Topical melatonin is experimental. Stacking all five without evaluating your individual hormonal picture, especially relevant if you're on TRT or any hormonal therapy, is not a strategy supported by any trial. If hair loss is significant, a dermatologist can run hormone panels and rule out thyroid dysfunction, iron deficiency, or other reversible causes before you commit to a supplement drawer full of DHT blockers.
- Ketoconazole 2% shampoo is the most evidence-backed item on this list, not pumpkin seed oil.
- Topical caffeine likely works by extending the hair growth phase, not by blocking DHT.
- Prescription finasteride and minoxidil remain the standard of care and were barely mentioned.
- Women with hair thinning should have thyroid, ferritin, and androgen levels checked before assuming DHT is the driver.
- Saw palmetto's evidence is real but modest, and the 27% figure comes from one 24-week trial.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 9 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @sofiahairhealth's DHT blocking claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging
Anchor review for copper peptide gene-expression and tissue-repair claims.
PubMed
Effects of glycyl-histidyl-lysine-Cu on wound healing
Search-backed PubMed trail for wound-healing claims where specific topical versus injectable context matters.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
@sofiahairhealth's DHT blocking claims, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
Androgenetic alopecia involves androgen-mediated miniaturization of hair follicles, with DHT playing a significant role in genetically predisposed individuals, though the picture in women is more complex and often involves multiple hormonal factors beyond DHT alone.
FormBlends verdict
Androgenetic alopecia involves androgen-mediated miniaturization of hair follicles, with DHT playing a significant role in genetically predisposed individuals, though the picture in women is more complex and often involves multiple hormonal factors beyond DHT alone. Sofia's video presents a supplement and topical stack as a primary intervention, but the clinical standard of care for androgenetic alopecia remains FDA-approved minoxidil and, where appropriate, prescription 5-alpha reductase inhibitors like finasteride. For patients on TRT or other hormonal therapies, hair loss management should be coordinated with the prescribing clinician, as exogenous testosterone converts to DHT and can accelerate follicle miniaturization.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Androgenetic alopecia involves androgen-mediated miniaturization of hair follicles, with DHT playing a significant role in genetically predisposed individuals, though the picture in women is more complex and often involves multiple hormonal factors beyond DHT alone. Sofia's video presents a supplement and topical stack as a primary intervention, but the clinical standard of care for androgenetic alopecia remains FDA-approved minoxidil and, where appropriate, prescription 5-alpha reductase inhibitors like finasteride. For patients on TRT or other hormonal therapies, hair loss management should be coordinated with the prescribing clinician, as exogenous testosterone converts to DHT and can accelerate follicle miniaturization.
- Ketoconazole 2% shampoo has more clinical trial support than pumpkin seed oil, yet Sofia ranked it second. Piérard-Franchimont et al. (1998) found it comparable to 2% minoxidil for hair density.
- The pumpkin seed oil 40% hair growth claim comes from one 2014 RCT with 76 male participants. That is real data, but it is one study in men only and has not been replicated at scale.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Ketoconazole 2% shampoo has more clinical trial support than pumpkin seed oil, yet Sofia ranked it second. Piérard-Franchimont et al. (1998) found it comparable to 2% minoxidil for hair density.
- The pumpkin seed oil 40% hair growth claim comes from one 2014 RCT with 76 male participants. That is real data, but it is one study in men only and has not been replicated at scale.
- Topical caffeine does not block DHT by current evidence. Its proposed mechanism is prolonging the anagen (growth) phase via phosphodiesterase inhibition, which is meaningfully different.
- Topical melatonin for hair loss is still experimental. Fischer et al. (2004) showed a signal, but calling it a DHT blocker is a mechanism claim the evidence does not yet support.
- FDA-approved treatments, minoxidil and prescription 5-alpha reductase inhibitors, were barely mentioned despite having the strongest evidence base for androgenetic alopecia in both men and women.
- Women with hair thinning should have ferritin, thyroid function, and androgen panels checked before assuming DHT is the primary driver. Androgenetic alopecia in women is hormonally more complex than this video implies.
- Patients on TRT should discuss hair loss with their prescribing clinician, since exogenous testosterone converts to DHT and can worsen androgenetic alopecia independent of any supplement stack.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Sofia Hair Health💗 · TikTok creator
477.9K views on this video
5 ways to block DHT ❤️ #hairloss #hairthinning #femalepatternhairloss #hairgrowth #androgenicalopecia
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Sofia Hair Health💗, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.